Treatment with SGLT2 Inhibitors in Patients with Diabetes Mellitus and Extensive Coronary Artery Disease: Mortality and Cardiovascular Outcomes.

David Chipayo-GonzalesAsad ShabbirCarlos Vergara-UzcateguiLuis Nombela-FrancoPilar Jimenez-QuevedoNieves GonzaloIvan Nuñez-GilHernan Mejia-RenteriaFernando Macaya-TenGabriela Tirado-ConteMaria Jose Perez-VizcaynoManuel FuentesJavier EscanedAntonio Fernandez-OrtizPablo Salinas

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2023)

In patients with T2DM and extensive CAD, treatment with SGLT2-I after discharge was associated with a reduced risk of all-cause death.

Keyphrases

coronary artery disease
cardiovascular events
type diabetes
metabolic syndrome
risk factors
acute coronary syndrome
coronary artery bypass grafting
combination therapy
adipose tissue
skeletal muscle
glycemic control
weight loss
aortic valve